Minimally Invasive Surgery For Patients With Spontaneous Deep Intracerebral Hemorrhage
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorHuynh Quoc Huy
About this trial
This observational cohort study evaluates the safety and effectiveness of minimally invasive surgery (MIS) compared with standard medical management in adults with spontaneous deep intracerebral hemorrhage. Consecutive patients admitted to People's Hospital 115 and Tam Anh General Hospital will be enrolled within 72 hours of onset. Clinical and imaging data will be collected prospectively, and outcomes including survival and functional status will be assessed through 180 days.
Eligibility criteria
Qualifiers
Age 18 to 80 years
Spontaneous basal ganglia intracerebral hemorrhage confirmed by non-contrast CT scan
Hematoma volume 30-80 mL (ABC/2 method)
Time from onset/last known well ≤ 72 hours
Disqualifiers
Secondary intracerebral hemorrhage due to trauma, tumor, vascular malformation, aneurysm, or hemorrhagic transformation of ischemic stroke
Infratentorial hemorrhage (brainstem or cerebellum)
Primary thalamic hemorrhage
Extensive intraventricular hemorrhage (>50% of one lateral ventricle)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 2 trial groupsSponsors and collaborators
Huynh Quoc Huy
Lead sponsor
115 People's Hospital
Sponsor institution
Source ClinicalTrials.gov